top of page


Yu Zhao
2024年7月12日読了時間: 9分
Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
閲覧数:1回0件のコメント


Yu Zhao
2023年10月13日読了時間: 6分
Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
閲覧数:3回0件のコメント


Yu Zhao
2023年10月4日読了時間: 5分
Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
閲覧数:1回0件のコメント

Yu Zhao
2023年9月12日読了時間: 1分
Implementing a PCCP for Class II SaMD Products Beyond AI/ML
This white paper provides a comprehensive analysis of the PCCP,
along with practical insights into implementation priorities and approaches
閲覧数:1回0件のコメント

Yu Zhao
2022年5月3日読了時間: 1分
Yu Zhao Co-Hosts Panel on Global AI-Based Medical Device Regulations at MedCon 2022
Yu Zhao co-hosted a panel on AI-based medical device regulations at MedCon 2022, discussing EU AI Act and U.S. FDA framework for SaMD.
閲覧数:0回0件のコメント
bottom of page